KAREN SKIDMORE: Open Payments
NPI 1568903326 · GONZALES, LA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$882 in 30 payments from 16 companies in 2025. Trend: 2023 $2,265 · 2024 $566 · 2025 $882
Food & beverage: $682Education: $200
| Company | Payments | Amount |
|---|---|---|
| Astellas Pharma US Inc | 4 | $184 |
| Janssen Biotech, Inc. | 3 | $142 |
| Antares Pharma, Inc. | 3 | $78 |
| Sumitomo Pharma America, Inc. | 3 | $76 |
| Medtronic, Inc. | 3 | $73 |
| ABBVIE INC. | 2 | $51 |
| Bayer Healthcare Pharmaceuticals Inc. | 2 | $46 |
| Azurity Pharmaceuticals, Inc. | 2 | $38 |
| Merck Sharp & Dohme LLC | 1 | $30 |
| Boston Scientific Corporation | 1 | $29 |
Products named: ERLEADA, Xtandi, XYOSTED, GEMTESA, INTERSTIM, BOTOX, Nubeqa, AZMIRO.
Industry payments across LA — which companies pay providers there.
